Patents Assigned to Upsher-Smith Laboratories, Inc.
-
Patent number: 9662340Abstract: Described are gel compositions containing active pharmaceutical ingredient such as testosterone, solvent, and thickener, the gel compositions being useful for transdermal administration of the active ingredient to a patient, and related methods. Certain embodiments of the gel composition specifically exclude Hsieh enhancer.Type: GrantFiled: March 25, 2016Date of Patent: May 30, 2017Assignee: UPSHER-SMITH LABORATORIES, INC.Inventor: Harish K. Pimplaskar
-
Publication number: 20170119808Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).Type: ApplicationFiled: November 21, 2016Publication date: May 4, 2017Applicant: Upsher-Smith Laboratories, Inc.Inventors: Sarah Michelle BETTERMAN, Jaidev Srinivas TANTRY, Laura Marie PATRICK
-
Patent number: 9555005Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).Type: GrantFiled: June 5, 2015Date of Patent: January 31, 2017Assignee: Upsher-Smith Laboratories, Inc.Inventors: Sarah Michelle Betterman, Jaidev Srinivas Tantry, Laura Marie Patrick
-
Publication number: 20160310508Abstract: Described are gel compositions containing active pharmaceutical ingredient such as testosterone, solvent, and thickener, the gel compositions being useful for transdermal administration of the active ingredient to a patient, and related methods. Certain embodiments of the gel composition specifically exclude Hsieh enhancer.Type: ApplicationFiled: March 25, 2016Publication date: October 27, 2016Applicant: Upsher-Smith Laboratories, Inc.Inventor: Harish K. Pimplaskar
-
Patent number: 9456970Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.Type: GrantFiled: September 11, 2015Date of Patent: October 4, 2016Assignee: Upsher-Smith Laboratories, Inc.Inventors: Gloria A. Rood, Kenneth L. Evenstad, Victoria A. O'Neill
-
Patent number: 9456985Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.Type: GrantFiled: April 28, 2015Date of Patent: October 4, 2016Assignee: UPSHER-SMITH LABORATORIES, INC.Inventors: Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Sean B. Mahoney, Stephen M. Berge
-
Patent number: 9295675Abstract: Described are gel compositions containing active pharmaceutical ingredient such as testosterone, solvent, and thickener, the gel compositions being useful for transdermal administration of the active ingredient to a patient, and related methods. Certain embodiments of the gel composition specifically exclude Hsieh enhancer.Type: GrantFiled: June 17, 2014Date of Patent: March 29, 2016Assignee: Upsher-Smith Laboratories, Inc.Inventor: Harish K. Pimplaskar
-
Publication number: 20160051475Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an amine-containing compound (e.g., an opioid) (including salts thereof) and a pharmaceutically acceptable salt of a non-NSAID cyclic organic acid compound.Type: ApplicationFiled: September 11, 2015Publication date: February 25, 2016Applicant: Upsher-Smith Laboratories, Inc.Inventors: Ronnie Ortiz, James S. Jensen, Kristopher R. Lundell, Victoria Ann O'Neill, Sean Mahoney
-
Publication number: 20160000672Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.Type: ApplicationFiled: September 11, 2015Publication date: January 7, 2016Applicant: UPSHER-SMITH LABORATORIES, INC.Inventors: GLORIA A. ROOD, KENNETH L. EVENSTAD, VICTORIA A. O'NEILL
-
Publication number: 20150265544Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).Type: ApplicationFiled: June 5, 2015Publication date: September 24, 2015Applicant: UPSHER-SMITH LABORATORIES, INC.Inventors: Sarah Michelle Betterman, Jaidev Srinivas Tantry, Laura Marie Patrick
-
Publication number: 20150238423Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.Type: ApplicationFiled: April 28, 2015Publication date: August 27, 2015Applicant: UPSHER-SMITH LABORATORIES, INC.Inventors: CHRISTIAN F. WERTZ, JAMES S. JENSEN, VICTORIA ANN O'NEILL, SEAN B. MAHONEY, STEPHEN M. BERGE
-
Patent number: 9101545Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).Type: GrantFiled: March 14, 2014Date of Patent: August 11, 2015Assignee: UPSHER-SMITH LABORATORIES, INC.Inventors: Sarah Michelle Betterman, Jaidev Srinivas Tantry, Laura Marie Patrick
-
Patent number: 9023390Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.Type: GrantFiled: December 31, 2009Date of Patent: May 5, 2015Assignee: Upsher-Smith Laboratories, Inc.Inventors: Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Sean B. Mahoney, Stephen M. Berge
-
Patent number: 8987291Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an opioid (including salts thereof) and a salt of a non-steroidal anti-inflammatory drug (NSAID).Type: GrantFiled: December 14, 2012Date of Patent: March 24, 2015Assignee: Upsher Smith Laboratories, Inc.Inventors: Kenneth L. Evenstad, Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Stephen M. Berge
-
Patent number: 8889190Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).Type: GrantFiled: January 17, 2014Date of Patent: November 18, 2014Assignee: Upsher-Smith Laboratories, Inc.Inventors: Sarah Michelle Betterman, Jaidev Srinivas Tantry, Laura Marie Patrick
-
Publication number: 20140287037Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).Type: ApplicationFiled: January 17, 2014Publication date: September 25, 2014Applicant: UPSHER-SMITH LABORATORIES, INC.Inventors: Sarah Michelle Betterman, Jaidev Srinivas Tantry, Laura Marie Patrick
-
Publication number: 20140271839Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).Type: ApplicationFiled: March 14, 2014Publication date: September 18, 2014Applicant: Upsher-Smith Laboratories, Inc.Inventors: Sarah Michelle Betterman, Jaidev Srinivas Tantry, Laura Marie Patrick
-
Patent number: 8785426Abstract: Described are gel compositions containing active pharmaceutical ingredient such as testosterone, solvent, and thickener, the gel compositions being useful for transdermal administration of the active ingredient to a patient, and related methods. Certain embodiments of the gel composition specifically exclude Hsieh enhancer.Type: GrantFiled: February 11, 2014Date of Patent: July 22, 2014Assignee: Upsher-Smith Laboratories, Inc.Inventor: Harish K. Pimplaskar
-
Patent number: 8652527Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).Type: GrantFiled: March 19, 2013Date of Patent: February 18, 2014Assignee: Upsher-Smith Laboratories, IncInventors: Sarah Michelle Betterman, Jaidev Srinvas Tantry, Laura Marie Patrick
-
Publication number: 20130123293Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an opioid (including salts thereof) and a salt of a non-steroidal anti-inflammatory drug (NSAID).Type: ApplicationFiled: December 14, 2012Publication date: May 16, 2013Applicant: UPSHER-SMITH LABORATORIES, INC.Inventor: UPSHER-SMITH LABORATORIES, INC.